ICRS 2018

Vascular Targeting of Nano Carriers in Arterial Bifurcations

Maria Khoury Mark Epshtein Netanel Korin
Biomedical Engineering, Technion-Israel Institute of Technology, Haifa, Israel

Drug targeting to sites of disease is a multistep process, which is based on the transport of drug carriers to the target region followed by deposition of drug carriers at the desired destination1. Important flow parameters including Reynolds number and flow characteristics differ significantly at artery bifurcations, and are highly dependent on vessel geometry and blood flow pattern2. The goal of our research is to understand particle dynamics, deposition and adhesion in models of arterial bifurcations under physiological conditions. We have designed and fabricated 3D artery models cultured with human umbilical vein endothelial cells. The models were connected to a programmable perfusion system for injection of particles. Our results show that the particles tend to localize at specific sites within the bifurcation based on hemodynamics and particles properties. These findings highlight the key role of hemodynamics in the development of vascular targeting of nano-carriers.

1 Simone, E., Ding, B. S. & Muzykantov, V. Targeted delivery of therapeutics to endothelium. Cell Tissue Res 335, 283-300, (2009).

2 Zarins, C. K. et al. Carotid Bifurcation Atherosclerosis Quantitative Correlation of Plaque Localization with Flow Velocity Profiles and Wall Shear-Stress. Circ Res 53, 502-514 (1983).









Powered by Eventact EMS